Physician profile
Hantz C Hercule
NPI 1336232784
$95,193.89
in general payments reported to CMS, 2019-2025
7 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $7,278 · 2021: $7,050 · 2022: $11K · 2023: $9,083 · 2024: $12K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $60K · Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $59,745.00 |
| Food and Beverage | $313.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $59,745.00 | 2023-2025 | |
| Csl Behring | $34,350.00 | 2019-2022 | |
| Novo Nordisk INC | $702.39 | 2020-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $208.92 | 2019-2025 | Zepbound, Mounjaro |
| Viiv Healthcare Company | $99.38 | 2025 | Apretude |
| Bayer Healthcare Pharmaceuticals INC. | $61.20 | 2023 | |
| Amgen INC. | $27.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hantz Hercule listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.